Will "The likely first longevity drug is based on s..." make the top fifty posts in LessWrong's 2023 Annual Review?
Basic
1
Ṁ45Feb 1
14%
chance
1D
1W
1M
ALL
As part of LessWrong's Annual Review, the community nominates, writes reviews, and votes on the most valuable posts. Posts are reviewable once they have been up for at least 12 months, and the 2023 Review resolves in February 2025.
This market will resolve to 100% if the post The likely first longevity drug is based on sketchy science. This is bad for science and bad for longevity. is one of the top fifty posts of the 2023 Review, and 0% otherwise. The market was initialized to 14%.
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Related questions
Related questions
Will "A primer on the current state of longevity re..." make the top fifty posts in LessWrong's 2024 Annual Review?
18% chance
Will "Significantly Enhancing Adult Intelligence Wi..." make the top fifty posts in LessWrong's 2023 Annual Review?
68% chance
Will "Things I Learned by Spending Five Thousand Ho..." make the top fifty posts in LessWrong's 2023 Annual Review?
70% chance
Will "My Objections to "We’re All Gonna Die with El..." make the top fifty posts in LessWrong's 2023 Annual Review?
49% chance
Will "Things I Learned by Spending Five Thousand Ho..." make the top fifty posts in LessWrong's 2023 Annual Review?
70% chance
Will "Optimistic Assumptions, Longterm Planning, an..." make the top fifty posts in LessWrong's 2024 Annual Review?
34% chance
Will "AI Timelines" make the top fifty posts in LessWrong's 2023 Annual Review?
79% chance
Will "re: Yudkowsky on biological materials" make the top fifty posts in LessWrong's 2023 Annual Review?
19% chance
Will "How to (hopefully ethically) make money off o..." make the top fifty posts in LessWrong's 2023 Annual Review?
24% chance
Will "Model Organisms of Misalignment: The Case for..." make the top fifty posts in LessWrong's 2023 Annual Review?
79% chance